OECD Health Working Papers
This series is designed to make available to a wider readership health studies prepared for use within the OECD. Authorship is usually collective, but principal writers are named. The papers are generally available only in their original language - English or French - with a summary in the other.
- ISSN: 18152015 (online)
- https://doi.org/10.1787/18152015
Performance-based managed entry agreements for new medicines in OECD countries and EU member states
How they work and possible improvements going forward
This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines.
JEL:
H51: Public Economics / National Government Expenditures and Related Policies / Government Expenditures and Health;
O32: Economic Development, Innovation, Technological Change, and Growth / Innovation; Research and Development; Technological Change; Intellectual Property Rights / Management of Technological Innovation and R&D;
I11: Health, Education, and Welfare / Health / Analysis of Health Care Markets;
O38: Economic Development, Innovation, Technological Change, and Growth / Innovation; Research and Development; Technological Change; Intellectual Property Rights / Technological Change: Government Policy;
I13: Health, Education, and Welfare / Health / Health Insurance, Public and Private
- Click to access:
-
Click to download PDF - 1.85MBPDF
-
Click to Read online and shareREAD